Vanthys is modeled after Lilly's early-stage development division, Chorus (www.choruspharma.com), which provides fast and efficient drug development exclusively through the utilization of external contract companies.

More about Vanthys

Vanthys Pharmaceutical Development (P) Ltd, http://www.vanthys.net, is a 50:50 joint venture of Eli Lilly and Company (USA) and Jubilant Organosys (India). The focus of the company is to efficiently advance drug candidate molecules from Discovery through Clinical Proof of Concept (PoC).

The mission of the company is to deliver definitive PoC data enabling our business partners to efficiently make decisions on the development of a stream of innovative molecules. The goal of Vanthys is to deliver data that permits further investment decisions.

Vanthys is modeled after Chorus (www.Choruspharma.com), an autonomous drug development organization within Lilly. Vanthys uses an integrated virtual drug development platform utilizing the scientific expertise within the company to run functional development activities through various third party partners.

If you would like to find out more about Vanthys, or have specific questions, please feel free to contact us via email by completing the information on the Contact Us page at http://www.vanthys.net/contact-us.php. You can also find us on your favorite search engine!

Axxiem's Focus on Life Sciences technologies

Our unique web expertise in the Biotechnology and Pharmeceutical industries enable us to play a key role on your strategy team - a role we are proud to play.

In our ongoing partner relationship, we ensure your online presence remains consistent with your objectives.  We employ the latest available technologies to help your business operate more efficiently and effectively.  Axxiem is also on the forefront of expanding available web technologies and security protocols to our customers in both hardware and software.

Today, Axxiem has the largest biotech portfolio on the web, having established ongoing development and hosting relationships with leading firms including Eli Lilly, Regeneron Pharmaceuticals, The Medicines Company, nContact Surgical, and many others.

Axxiem Web Solutions, http://www.axxiem.com, is headquartered in New York with offices across the U.S. and India.  As the BioTech industry’s leader in web development, Axxiem has a dedicated Life Sciences department with years of experience in the industry.  To learn more about Axxiem, please visit our site at http://www.axxiem.com.  You may also view our clients’ sites and read about our involvement in the Bio Technology industry on our Life Sciences & Healthcare portfolio at http://www.axxiem.com/Life_Sciences__Healthcare-p-4.html